These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21573702)

  • 1. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
    Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
    Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amurensin G inhibits angiogenesis and tumor growth of tamoxifen-resistant breast cancer via Pin1 inhibition.
    Kim JA; Kim MR; Kim O; Phuong NT; Yun J; Oh WK; Bae K; Kang KW
    Food Chem Toxicol; 2012 Oct; 50(10):3625-34. PubMed ID: 22842120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression.
    Kim MR; Choi HS; Yang JW; Park BC; Kim JA; Kang KW
    Mol Cancer Ther; 2009 Aug; 8(8):2163-71. PubMed ID: 19671742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
    Kim MR; Choi HK; Cho KB; Kim HS; Kang KW
    Cancer Sci; 2009 Oct; 100(10):1834-41. PubMed ID: 19681904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells.
    Oh SJ; Kim O; Lee JS; Kim JA; Kim MR; Choi HS; Shim JH; Kang KW; Kim YC
    Food Chem Toxicol; 2010 Nov; 48(11):3227-34. PubMed ID: 20804812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
    Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
    Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells.
    Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA
    Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of ErbB2 expression by cAMP-dependent protein kinase in tamoxifen-resistant breast cancer cells.
    Yang JW; Kim MR; Kim HG; Kim SK; Jeong HG; Kang KW
    Arch Pharm Res; 2008 Mar; 31(3):350-6. PubMed ID: 18409049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells.
    Kim SK; Yang JW; Kim MR; Roh SH; Kim HG; Lee KY; Jeong HG; Kang KW
    Free Radic Biol Med; 2008 Aug; 45(4):537-46. PubMed ID: 18539158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
    Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
    Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
    Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLF4 overcomes tamoxifen resistance by suppressing MAPK signaling pathway and predicts good prognosis in breast cancer.
    Jia Y; Zhou J; Luo X; Chen M; Chen Y; Wang J; Xiong H; Ying X; Hu W; Zhao W; Deng W; Wang L
    Cell Signal; 2018 Jan; 42():165-175. PubMed ID: 28988130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells.
    Choi HK; Yang JW; Roh SH; Han CY; Kang KW
    Endocr Relat Cancer; 2007 Jun; 14(2):293-303. PubMed ID: 17639045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation.
    Phuong NT; Lim SC; Kim YM; Kang KW
    Cancer Lett; 2014 Aug; 351(1):91-9. PubMed ID: 24836190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells.
    Phuong NT; Kim SK; Lim SC; Kim HS; Kim TH; Lee KY; Ahn SG; Yoon JH; Kang KW
    Breast Cancer Res Treat; 2011 Nov; 130(1):73-83. PubMed ID: 21170675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells.
    Kim MR; Choi HS; Heo TH; Hwang SW; Kang KW
    Biochem Biophys Res Commun; 2008 May; 369(2):547-53. PubMed ID: 18294451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.
    Namgoong GM; Khanal P; Cho HG; Lim SC; Oh YK; Kang BS; Shim JH; Yoo JC; Choi HS
    J Biol Chem; 2010 Jul; 285(31):23829-41. PubMed ID: 20479004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.
    Rajbhandari P; Finn G; Solodin NM; Singarapu KK; Sahu SC; Markley JL; Kadunc KJ; Ellison-Zelski SJ; Kariagina A; Haslam SZ; Lu KP; Alarid ET
    Mol Cell Biol; 2012 Jan; 32(2):445-57. PubMed ID: 22064478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
    Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH
    BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer.
    Lucchetti C; Caligiuri I; Toffoli G; Giordano A; Rizzolio F
    PLoS One; 2013; 8(2):e55355. PubMed ID: 23390529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.